Literature DB >> 31262826

Pandemic fluoroquinolone resistant Escherichia coli clone ST1193 emerged via simultaneous homologous recombinations in 11 gene loci.

Veronika Tchesnokova1, Matthew Radey1, Sujay Chattopadhyay2, Lydia Larson1, Jamie Lee Weaver1, Dagmara Kisiela1, Evgeni V Sokurenko3.   

Abstract

Global growth in antibiotic resistance is a major social problem. A high level of resistance to fluoroquinolones requires the concurrent presence of at least 3 mutations in the target proteins-2 in DNA gyrase (GyrA) and 1 in topoisomerase IV (ParC), which occur in a stepwise manner. In the Escherichia coli chromosome, the gyrA and parC loci are positioned about 1 Mb away from each other. Here we show that the 3 fluoroquinolone resistance mutations are tightly associated genetically in naturally occurring strains. In the latest pandemic uropathogenic and multidrug-resistant E. coli clonal group ST1193, the mutant variants of gyrA and parC were acquired not by a typical gradual, stepwise evolution but all at once. This happened as part of 11 simultaneous homologous recombination events involving 2 phylogenetically distant strains of E. coli, from an uropathogenic clonal complex ST14 and fluoroquinolone-resistant ST10. The gene exchanges swapped regions between 0.5 and 139 Kb in length (183 Kb total) spread along 976 Kb of chromosomal DNA around and between gyrA and parC loci. As a result, all 3 fluoroquinolone resistance mutations in GyrA and ParC have simultaneously appeared in ST1193. Based on molecular clock estimates, this potentially happened as recently as <12 y ago. Thus, naturally occurring homologous recombination events between 2 strains can involve numerous chromosomal gene locations simultaneously, resulting in the transfer of distant but tightly associated genetic mutations and emergence of a both highly pathogenic and antibiotic-resistant strain with a rapid global spread capability.

Entities:  

Keywords:  Escherichia coli ST1193; QRDR mutations; homologous recombination; resistance to fluoroquinolones; urinary tract infections

Year:  2019        PMID: 31262826      PMCID: PMC6642405          DOI: 10.1073/pnas.1903002116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  60 in total

1.  Evolution of Staphylococcus aureus by large chromosomal replacements.

Authors:  D Ashley Robinson; Mark C Enright
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

2.  Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.

Authors:  Hafizah Y Chenia; Balakrishna Pillay; Dorsamy Pillay
Journal:  J Antimicrob Chemother       Date:  2006-10-13       Impact factor: 5.790

Review 3.  Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments.

Authors:  Katie L Hopkins; Robert H Davies; E John Threlfall
Journal:  Int J Antimicrob Agents       Date:  2005-05       Impact factor: 5.283

Review 4.  Molecular epidemiology of Escherichia coli mediated urinary tract infections.

Authors:  Lixin Zhang; Betsy Foxman
Journal:  Front Biosci       Date:  2003-01-01

5.  Recombination in Escherichia coli and the definition of biological species.

Authors:  D E Dykhuizen; L Green
Journal:  J Bacteriol       Date:  1991-11       Impact factor: 3.490

6.  Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections.

Authors:  Patricia Komp Lindgren; Asa Karlsson; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

7.  Shaping a bacterial genome by large chromosomal replacements, the evolutionary history of Streptococcus agalactiae.

Authors:  Mathieu Brochet; Christophe Rusniok; Elisabeth Couvé; Shaynoor Dramsi; Claire Poyart; Patrick Trieu-Cuot; Frank Kunst; Philippe Glaser
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-02       Impact factor: 11.205

8.  Sex and virulence in Escherichia coli: an evolutionary perspective.

Authors:  Thierry Wirth; Daniel Falush; Ruiting Lan; Frances Colles; Patience Mensa; Lothar H Wieler; Helge Karch; Peter R Reeves; Martin C J Maiden; Howard Ochman; Mark Achtman
Journal:  Mol Microbiol       Date:  2006-06       Impact factor: 3.501

9.  Hybrid Vibrio vulnificus.

Authors:  Naiel Bisharat; Daniel I Cohen; Rosalind M Harding; Daniel Falush; Derrick W Crook; Tim Peto; Martin C Maiden
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

10.  Recombination speeds adaptation by reducing competition between beneficial mutations in populations of Escherichia coli.

Authors:  Tim F Cooper
Journal:  PLoS Biol       Date:  2007-09       Impact factor: 8.029

View more
  14 in total

1.  Origin and Evolution of Hybrid Shiga Toxin-Producing and Uropathogenic Escherichia coli Strains of Sequence Type 141.

Authors:  Noble Selasi Gati; Barbara Middendorf-Bauchart; Stefan Bletz; Ulrich Dobrindt; Alexander Mellmann
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

Review 2.  The population genetics of pathogenic Escherichia coli.

Authors:  Erick Denamur; Olivier Clermont; Stéphane Bonacorsi; David Gordon
Journal:  Nat Rev Microbiol       Date:  2020-08-21       Impact factor: 60.633

Review 3.  Escherichia coli ST1193: Following in the Footsteps of E. coli ST131.

Authors:  Johann D D Pitout; Gisele Peirano; Liang Chen; Rebekah DeVinney; Yasufumi Matsumura
Journal:  Antimicrob Agents Chemother       Date:  2022-06-06       Impact factor: 5.938

4.  A Comparative Study of Fluoroquinolone-Resistant Escherichia coli Lineages Portrays Indistinguishable Pathogenicity- and Survivability-Associated Phenotypic Characteristics Between ST1193 and ST131.

Authors:  Jiangqing Huang; Shengcen Zhang; Shuyu Zhang; Zhichang Zhao; Yingping Cao; Min Chen; Bin Li
Journal:  Infect Drug Resist       Date:  2020-11-20       Impact factor: 4.003

5.  Plasmids shape the diverse accessory resistomes of Escherichia coli ST131.

Authors:  Arun Gonzales Decano; Nghia Tran; Hawriya Al-Foori; Buthaina Al-Awadi; Leigh Campbell; Kevin Ellison; Louisse Paolo Mirabueno; Maddy Nelson; Shane Power; Genevieve Smith; Cian Smyth; Zoe Vance; Caitriona Woods; Alexander Rahm; Tim Downing
Journal:  Access Microbiol       Date:  2020-11-18

6.  Population Bottlenecks Strongly Influence the Evolutionary Trajectory to Fluoroquinolone Resistance in Escherichia coli.

Authors:  Linnéa Garoff; Franziska Pietsch; Douglas L Huseby; Tua Lilja; Gerrit Brandis; Diarmaid Hughes
Journal:  Mol Biol Evol       Date:  2020-06-01       Impact factor: 16.240

7.  Genotypic antimicrobial resistance characterization of E. coli from dairy calves at high risk of respiratory disease administered enrofloxacin or tulathromycin.

Authors:  R V Pereira; C Foditsch; J D Siler; S C Dulièpre; C Altier; A Garzon; L D Warnick
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

8.  Whole-genome analyses of extended-spectrum or AmpC β-lactamase-producing Escherichia coli isolates from companion dogs in Japan.

Authors:  Mayo Yasugi; Shingo Hatoya; Daisuke Motooka; Yuki Matsumoto; Shunsuke Shimamura; Hiroyuki Tani; Masaru Furuya; Keiichiro Mie; Masami Miyake; Shota Nakamura; Terumasa Shimada
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

9.  Isolation of Human Lineage, Fluoroquinolone-Resistant and Extended-β-Lactamase-Producing Escherichia coli Isolates from Companion Animals in Japan.

Authors:  Toyotaka Sato; Shin-Ichi Yokota; Tooru Tachibana; Satoshi Tamai; Shigeki Maetani; Yutaka Tamura; Motohiro Horiuchi
Journal:  Antibiotics (Basel)       Date:  2021-11-28

10.  Enhanced Biosynthesis of Fatty Acids Is Associated with the Acquisition of Ciprofloxacin Resistance in Edwardsiella tarda.

Authors:  Yu-Bin Su; Su-Fang Kuang; Jin-Zhou Ye; Jian-Jun Tao; Hui Li; Xuan-Xian Peng; Bo Peng
Journal:  mSystems       Date:  2021-08-24       Impact factor: 6.496

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.